Friday, January 18, 2019
Cervical cancer treatment market 2018-2026: Global Opportunities, Demand, Size, Share and and Future Growth Analysis Report
Do you like this story?
The latest market report published by Credence Research,
Inc. “Global Cervical
Cancer Treatment Market - Growth, Future Prospects, Competitive
Analysis, 2018 - 2026,” the global cervical cancer treatment market
is expected to expand at a CAGR of 5.2% from 2018 to 2026.
Market Insights
According to the latest research citings of World Health
Organization (WHO) in 2018, approximately 570,000 new cases if cervical cancer
were reported which eventually represents 6.6% of all female cancers. The early
manifestation of cervical cancer are vaginal bleeding after sexual intercourse
with excruciating pain. The 2 main types of cervical cancer are squamous cell
carcinoma and adenocarcinoma. Early diagnosis and vaccination with Gardasil can
prevent the advent of cervical cancer. In the last decade there has been a
paradigm shift in the treatment regimen from chemotherapy to targeted therapy.
Biologics in the phase III clinical trials such as nimotuzumab and atezolizumab
will provide a positive thrust to the cervical cancer treatment market growth.
Get Sample with more
graphs and details for better understanding: https://www.credenceresearch.com/sample-request/59521
Browse the full report Cervical Cancer Treatment Market
- Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report
at https://www.credenceresearch.com/report/cervical-cancer-treatment-market
Chemotherapy is reigning the product segment for cervical
cancer treatment market. Placitaxel, cisplatin, carboplatin, gemcitabine are
given either alone or in combination with radiation therapy for patients
suffering with advanced stage cervical cancer. The combination therapy is
helpful but causes severe adverse effects. Cervical hysterectomy is helpful in
women suffering with early stage cervical cancer. Targeted drug therapy will be
the fastest growing market on account of its excellent clinical outcomes, dose
tolerability and patient compliance.
North America presently maintains supremacy in the regional
segment for cervical cancer treatment market. According to Center for Disease
Control And Prevention (CDC), cervical cancer is the second most common type of
cancer in women after breast cancer resulting in mortality due to lack of early
screening and medical intervention. Rising public health awareness and affordable
reimbursement scenario drive the cervical cancer treatment market growth in
North America. In Europe cervical cancer is responsible for the mortality of
70% patient actively diagnosed with cervical cancer. Presence of key players
such as F.Hoffman La-Roche AG., Merck & Co., Inc., and GlaxoSmithkline,
Plc. etc. propel the cervical cancer treatment market growth in the European
Region. Asia Pacific will be the fastest growing market during the forecast
period owing to the presence of huge generic market and proactive government
policies to fight cervical cancer.
Biopharmaceutical companies having a strong foothold in the
cervical cancer treatment market are, Allergan, Plc., Biocon Ltd.,
CooperSurgical, Inc., Eli Lilly & Company, F.Hoffman La-Roche AG, GlaxoSmithkline
Plc., Ethicon, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd.
and Varian Medical Systems, Inc.
Key Market Movements:
- Increasing
cases of women being diagnosed for cervical cancer throughout the globe
- Rising
public health awareness and affordable reimbursement scenario for the
generic drugs employed for the treatment of cervical cancer
- Vaccination
such as Gardasil is helpful in prevention of HPV infection and strong
biologics pipeline with drugs in phase III clinical trials such as nimotuzumab
and atezolizumab
Browse the full report Cervical Cancer Treatment Market
- Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report
at https://www.credenceresearch.com/report/cervical-cancer-treatment-market
About Us
Credence Research is a worldwide market research and
counseling firm that serves driving organizations, governments, non legislative
associations, and not-for-benefits. We offer our customers some assistance with
making enduring enhancements to their execution and understand their most
imperative objectives. Over almost a century, we've manufactured a firm extraordinarily
prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than
15 research consultants and almost 100 research and information professionals. Our
customers mirror our worldwide nature. Around 45% are in Europe, 30% in the
Americas, 13% in Asia Pacific and 12% in the Middle East and Africa. Our firm
is intended to work as one. We are a solitary global research organization
united by a solid arrangement of qualities, concentrated on customer effect.
Credence Research Inc
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free(US/CANADA): +1-800-361-8290
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free(US/CANADA): +1-800-361-8290
Email: sales@credenceresearch.com
Subscribe to:
Post Comments (Atom)
0 Responses to “Cervical cancer treatment market 2018-2026: Global Opportunities, Demand, Size, Share and and Future Growth Analysis Report”
Post a Comment